Early research (Phase 1)Study completedNCT01346540
What this trial is testing
A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.
Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 16